Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 303

1.

Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis).

Liu CY, Liu YC, Wu C, Armstrong A, Volpe GJ, van der Geest RJ, Liu Y, Hundley WG, Gomes AS, Liu S, Nacif M, Bluemke DA, Lima JA.

J Am Coll Cardiol. 2013 Oct 1;62(14):1280-7. doi: 10.1016/j.jacc.2013.05.078. Epub 2013 Jul 17.

2.

Interstitial fibrosis, left ventricular remodeling, and myocardial mechanical behavior in a population-based multiethnic cohort: the Multi-Ethnic Study of Atherosclerosis (MESA) study.

Donekal S, Venkatesh BA, Liu YC, Liu CY, Yoneyama K, Wu CO, Nacif M, Gomes AS, Hundley WG, Bluemke DA, Lima JA.

Circ Cardiovasc Imaging. 2014 Mar;7(2):292-302. doi: 10.1161/CIRCIMAGING.113.001073. Epub 2014 Feb 18.

3.

The association between cardiovascular risk and cardiovascular magnetic resonance measures of fibrosis: the Multi-Ethnic Study of Atherosclerosis (MESA).

Yi CJ, Wu CO, Tee M, Liu CY, Volpe GJ, Prince MR, Hundley GW, Gomes AS, van der Geest RJ, Heckbert S, Lima JA, Bluemke DA.

J Cardiovasc Magn Reson. 2015 Feb 12;17:15. doi: 10.1186/s12968-015-0121-5.

4.

Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume.

Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S, Ray SG, Yonan N, Williams SG, Flett AS, Moon JC, Greiser A, Parker GJ, Schmitt M.

Circ Cardiovasc Imaging. 2013 May 1;6(3):373-83. doi: 10.1161/CIRCIMAGING.112.000192. Epub 2013 Apr 3.

5.

Detection of elevated right ventricular extracellular volume in pulmonary hypertension using Accelerated and Navigator-Gated Look-Locker Imaging for Cardiac T1 Estimation (ANGIE) cardiovascular magnetic resonance.

Mehta BB, Auger DA, Gonzalez JA, Workman V, Chen X, Chow K, Stump CJ, Mazimba S, Kennedy JL, Gay E, Salerno M, Kramer CM, Epstein FH, Bilchick KC.

J Cardiovasc Magn Reson. 2015 Dec 21;17:110. doi: 10.1186/s12968-015-0209-y.

6.

Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T.

de Meester de Ravenstein C, Bouzin C, Lazam S, Boulif J, Amzulescu M, Melchior J, Pasquet A, Vancraeynest D, Pouleur AC, Vanoverschelde JL, Gerber BL.

J Cardiovasc Magn Reson. 2015 Jun 11;17:48. doi: 10.1186/s12968-015-0150-0.

7.

T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region.

Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA.

J Cardiovasc Magn Reson. 2012 May 1;14:27. doi: 10.1186/1532-429X-14-27.

8.

Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.

Ntusi NA, Piechnik SK, Francis JM, Ferreira VM, Matthews PM, Robson MD, Wordsworth PB, Neubauer S, Karamitsos TD.

JACC Cardiovasc Imaging. 2015 May;8(5):526-36. doi: 10.1016/j.jcmg.2014.12.025. Epub 2015 Apr 15.

9.

T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.

White SK, Sado DM, Fontana M, Banypersad SM, Maestrini V, Flett AS, Piechnik SK, Robson MD, Hausenloy DJ, Sheikh AM, Hawkins PN, Moon JC.

JACC Cardiovasc Imaging. 2013 Sep;6(9):955-62. doi: 10.1016/j.jcmg.2013.01.011. Epub 2013 Apr 10.

10.

Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification.

Ntusi NA, Piechnik SK, Francis JM, Ferreira VM, Rai AB, Matthews PM, Robson MD, Moon J, Wordsworth PB, Neubauer S, Karamitsos TD.

J Cardiovasc Magn Reson. 2014 Mar 4;16:21. doi: 10.1186/1532-429X-16-21.

11.

Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions.

Neilan TG, Coelho-Filho OR, Shah RV, Abbasi SA, Heydari B, Watanabe E, Chen Y, Mandry D, Pierre-Mongeon F, Blankstein R, Kwong RY, Jerosch-Herold M.

JACC Cardiovasc Imaging. 2013 Jun;6(6):672-83. doi: 10.1016/j.jcmg.2012.09.020. Epub 2013 May 1.

12.

Assessment of diffuse myocardial fibrosis in rats using small-animal Look-Locker inversion recovery T1 mapping.

Messroghli DR, Nordmeyer S, Dietrich T, Dirsch O, Kaschina E, Savvatis K, O h-Ici D, Klein C, Berger F, Kuehne T.

Circ Cardiovasc Imaging. 2011 Nov;4(6):636-40. doi: 10.1161/CIRCIMAGING.111.966796. Epub 2011 Sep 14.

13.

T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA.

Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA.

J Cardiovasc Magn Reson. 2012 Apr 28;14:26. doi: 10.1186/1532-429X-14-26.

14.

Multi-ethnic study of atherosclerosis: association between left atrial function using tissue tracking from cine MR imaging and myocardial fibrosis.

Imai M, Ambale Venkatesh B, Samiei S, Donekal S, Habibi M, Armstrong AC, Heckbert SR, Wu CO, Bluemke DA, Lima JA.

Radiology. 2014 Dec;273(3):703-13. doi: 10.1148/radiol.14131971. Epub 2014 Jul 14.

15.

Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials.

Liu S, Han J, Nacif MS, Jones J, Kawel N, Kellman P, Sibley CT, Bluemke DA.

J Cardiovasc Magn Reson. 2012 Dec 28;14:90. doi: 10.1186/1532-429X-14-90.

16.

Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR.

Fontana M, White SK, Banypersad SM, Sado DM, Maestrini V, Flett AS, Piechnik SK, Neubauer S, Roberts N, Moon JC.

J Cardiovasc Magn Reson. 2012 Dec 28;14:88. doi: 10.1186/1532-429X-14-88.

17.

Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study.

Dabir D, Child N, Kalra A, Rogers T, Gebker R, Jabbour A, Plein S, Yu CY, Otton J, Kidambi A, McDiarmid A, Broadbent D, Higgins DM, Schnackenburg B, Foote L, Cummins C, Nagel E, Puntmann VO.

J Cardiovasc Magn Reson. 2014 Oct 21;16:69. doi: 10.1186/s12968-014-0069-x.

18.

MOLLI and AIR T1 mapping pulse sequences yield different myocardial T1 and ECV measurements.

Hong K, Kim D.

NMR Biomed. 2014 Nov;27(11):1419-26. doi: 10.1002/nbm.3221.

19.

Reference values of myocardial structure, function, and tissue composition by cardiac magnetic resonance in healthy African-Americans at 3T and their relations to serologic and cardiovascular risk factors.

Liu CY, Bluemke DA, Gerstenblith G, Zimmerman SL, Li J, Zhu H, Lai S, Lai H.

Am J Cardiol. 2014 Sep 1;114(5):789-95. doi: 10.1016/j.amjcard.2014.06.007. Epub 2014 Jun 19.

PMID:
25037675
20.

T1 mapping for diffuse myocardial fibrosis: a key biomarker in cardiac disease?

Moon JC, Treibel TA, Schelbert EB.

J Am Coll Cardiol. 2013 Oct 1;62(14):1288-9. doi: 10.1016/j.jacc.2013.05.077. Epub 2013 Jul 17. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk